Homepage
Scientists discover a highly potent antibody against SARS-CoV-2
Researchers involved in the CARE project have isolated a highly potent monoclonal antibody against SARS-CoV-2, one of the most powerful identified so far
Surge vaccine production principles now written into EU law
Surge vaccine production principles now written into EU law moreVaccine trials for hospital superbugs need a radical rethink
Vaccine trials for hospital superbugs need a radical rethink morePublications from IMI projects are cited at twice the global average rate
Publications from IMI projects are cited at twice the global average rate more
IMI – radical collaboration in action
A new brochure, 'IMI - radical collaboration in action', showcases some recent IMI project successes, which include an approved vaccine for Ebola, insights into the genetics of Alzheimer’s disease, a new classification of diabetes, and advances on using liquid biopsies for cancer, as well as contributions to the fight against COVID-19.
IMI covid-19 response
Within weeks of the first reports of coronavirus in Europe, IMI launched a fast-track Call for proposals to develop therapeutics and diagnostics for current and future coronavirus outbreaks